Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MMS19 cytosolic iron-sulfur assembly component (MMS19) is a multi-domain adapter protein crucial for iron-sulfur (Fe-S) cluster assembly and delivery to apoproteins, particularly those involved in fundamental DNA metabolic processes and genomic stability. MMS19 is a key component of the cytosolic iron-sulfur protein assembly (CIA) complex, where it enables the incorporation of Fe-S clusters into DNA repair and replication factors such as ERCC2/XPD, FANCJ, and RTEL1, supporting multiple DNA repair pathways including nucleotide excision repair (NER) and homologous recombination. It also participates in the MMXD complex, contributing to mitotic spindle assembly and chromosome segregation. Additionally, MMS19 acts as a transcriptional coactivator by facilitating proper Fe-S cluster incorporation into TFIIH machinery, thereby modulating RNA polymerase II transcription and the function of nuclear hormone receptors such as the estrogen receptor. Dysfunction of MMS19 has been associated with disorders of genome instability, such as Fanconi anemia and certain mitochondrial DNA diseases, and may play a role in cancer susceptibility[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MMS19 cytosolic iron-sulfur assembly component (MMS19).